EVALUATION OF PATIENT REPORTED OUTCOMES (PRO) IN OBESE PATIENTS IN AN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) PHASE 3 TRIAL

被引：0
|
作者：
Corey, G. R. [1 ]
Gupta, K. [2 ]
Henry, E. [3 ]
McGinnis, E. [4 ]
Cammarata, S. [4 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Boston VA Healthcare Syst, Dept Med, West Roxbury, NC USA
[3] H2O Clin LLC, Hunt Valley, MD USA
[4] Melinta Therapeut, Lincolnshire, IL USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1412
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN88
引用
收藏
页码：A243 / A243
页数：1
相关论文
共 50 条
  • [1] DEVELOPMENT OF A NEW PATIENT REPORTED OUTCOME (PRO) MEASURE FOR ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI)
    Powers, J. H.
    Siuciak, J. A.
    Llorens, L.
    Talbot, G. H.
    Crawley, J.
    Halling, K.
    Cimms, T. A.
    DeBusk, K.
    Howard, K.
    VALUE IN HEALTH, 2013, 16 (03) : A46 - A46
  • [2] Tedizolid versus linezolid in acute bacterial skin and skin structure infections (ABSSSI): results of a phase 3 clinical trial
    Lv, Xiaoju
    O'riordan, William
    Zhu, Xu
    Zhang, Zhong Qi
    Alder, Jeff
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S191 - S192
  • [3] The incidence and patient outcomes of ABSSSI by iclaprim MIC values in the phase 3 REVIVE trials for treatment of acute bacterial skin and skin structure infections
    Huang, David B.
    Charrier, Cedric
    Le Bras, Chloe
    Hawser, Stephen
    Noviello, Stephanie
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (06) : 898 - 902
  • [4] Dalvance(TM) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (07) : 879 - 879
  • [5] Delafloxacin meglumine for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
    Kaul, G.
    Kapoor, E.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2018, 54 (11) : 657 - 666
  • [6] Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
    Leuthner, Kimberly D.
    Buechler, Kristin A.
    Kogan, David
    Saguros, Agafe
    Lee, H. Stephen
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 931 - 940
  • [7] Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI)
    Amara, Shilpa
    Adamson, Robert T.
    Lew, Indu
    Huang, Xingyue
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (07) : 869 - 877
  • [8] Ceftaroline Fosamil for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Obese Patients
    Evans, John D.
    Udeani, George
    Cole, Phillip
    Friedland, H. David
    POSTGRADUATE MEDICINE, 2014, 126 (05) : 128 - 134
  • [9] ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) SIGNS/SYMPTOMS AND PROS: A COMPREHENSIVE LITERATURE REVIEW
    Cimms, T. A.
    DeBusk, K.
    Howard, K.
    Siuciak, J. A.
    Llorens, L.
    Crawley, J.
    Halling, K.
    Powers, J. H.
    VALUE IN HEALTH, 2013, 16 (03) : A32 - A32
  • [10] ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSI): DEVELOPMENT OF A NEW PATIENT REPORTED OUTCOME (PRO)
    Powers, J. H.
    Portalupi, S.
    Devine, J.
    Saretsky, T. L.
    Hoffmann, S.
    Crawley, J.
    Lorens, L.
    Cimms, T. A.
    Howard, K.
    VALUE IN HEALTH, 2014, 17 (03) : A288 - A288
12345